Global Enasidenib Market Growth 2022-2028
- LP 4871644
- 74 Pages
- February 2022
- Pharmaceuticals
The United States Enasidenib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Enasidenib market, reaching US$ million by the year 2028. As for the Europe Enasidenib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Enasidenib players cover Celgene Corporation, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Enasidenib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
50mg
100mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Celgene Corporation
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Enasidenib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Enasidenib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Enasidenib by Country/Region, 2017, 2022 & 2028
2.2 Enasidenib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.3 Enasidenib Sales by Type
2.3.1 Global Enasidenib Sales Market Share by Type (2017-2022)
2.3.2 Global Enasidenib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Enasidenib Sale Price by Type (2017-2022)
2.4 Enasidenib Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Enasidenib Sales by Application
2.5.1 Global Enasidenib Sale Market Share by Application (2017-2022)
2.5.2 Global Enasidenib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Enasidenib Sale Price by Application (2017-2022)
3 Global Enasidenib by Company
3.1 Global Enasidenib Breakdown Data by Company
3.1.1 Global Enasidenib Annual Sales by Company (2020-2022)
3.1.2 Global Enasidenib Sales Market Share by Company (2020-2022)
3.2 Global Enasidenib Annual Revenue by Company (2020-2022)
3.2.1 Global Enasidenib Revenue by Company (2020-2022)
3.2.2 Global Enasidenib Revenue Market Share by Company (2020-2022)
3.3 Global Enasidenib Sale Price by Company
3.4 Key Manufacturers Enasidenib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enasidenib Product Location Distribution
3.4.2 Players Enasidenib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Enasidenib by Geographic Region
4.1 World Historic Enasidenib Market Size by Geographic Region (2017-2022)
4.1.1 Global Enasidenib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Enasidenib Annual Revenue by Geographic Region
4.2 World Historic Enasidenib Market Size by Country/Region (2017-2022)
4.2.1 Global Enasidenib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Enasidenib Annual Revenue by Country/Region
4.3 Americas Enasidenib Sales Growth
4.4 APAC Enasidenib Sales Growth
4.5 Europe Enasidenib Sales Growth
4.6 Middle East & Africa Enasidenib Sales Growth
5 Americas
5.1 Americas Enasidenib Sales by Country
5.1.1 Americas Enasidenib Sales by Country (2017-2022)
5.1.2 Americas Enasidenib Revenue by Country (2017-2022)
5.2 Americas Enasidenib Sales by Type
5.3 Americas Enasidenib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enasidenib Sales by Region
6.1.1 APAC Enasidenib Sales by Region (2017-2022)
6.1.2 APAC Enasidenib Revenue by Region (2017-2022)
6.2 APAC Enasidenib Sales by Type
6.3 APAC Enasidenib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Enasidenib by Country
7.1.1 Europe Enasidenib Sales by Country (2017-2022)
7.1.2 Europe Enasidenib Revenue by Country (2017-2022)
7.2 Europe Enasidenib Sales by Type
7.3 Europe Enasidenib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Enasidenib by Country
8.1.1 Middle East & Africa Enasidenib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Enasidenib Revenue by Country (2017-2022)
8.2 Middle East & Africa Enasidenib Sales by Type
8.3 Middle East & Africa Enasidenib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enasidenib
10.3 Manufacturing Process Analysis of Enasidenib
10.4 Industry Chain Structure of Enasidenib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enasidenib Distributors
11.3 Enasidenib Customer
12 World Forecast Review for Enasidenib by Geographic Region
12.1 Global Enasidenib Market Size Forecast by Region
12.1.1 Global Enasidenib Forecast by Region (2023-2028)
12.1.2 Global Enasidenib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enasidenib Forecast by Type
12.7 Global Enasidenib Forecast by Application
13 Key Players Analysis
13.1 Celgene Corporation
13.1.1 Celgene Corporation Company Information
13.1.2 Celgene Corporation Enasidenib Product Offered
13.1.3 Celgene Corporation Enasidenib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Celgene Corporation Main Business Overview
13.1.5 Celgene Corporation Latest Developments
14 Research Findings and Conclusion
Table 1. Enasidenib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Enasidenib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 100mg
Table 5. Global Enasidenib Sales by Type (2017-2022) & (K Units)
Table 6. Global Enasidenib Sales Market Share by Type (2017-2022)
Table 7. Global Enasidenib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Enasidenib Revenue Market Share by Type (2017-2022)
Table 9. Global Enasidenib Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Enasidenib Sales by Application (2017-2022) & (K Units)
Table 11. Global Enasidenib Sales Market Share by Application (2017-2022)
Table 12. Global Enasidenib Revenue by Application (2017-2022)
Table 13. Global Enasidenib Revenue Market Share by Application (2017-2022)
Table 14. Global Enasidenib Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Enasidenib Sales by Company (2020-2022) & (K Units)
Table 16. Global Enasidenib Sales Market Share by Company (2020-2022)
Table 17. Global Enasidenib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Enasidenib Revenue Market Share by Company (2020-2022)
Table 19. Global Enasidenib Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Enasidenib Producing Area Distribution and Sales Area
Table 21. Players Enasidenib Products Offered
Table 22. Enasidenib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Enasidenib Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Enasidenib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Enasidenib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Enasidenib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Enasidenib Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Enasidenib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Enasidenib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Enasidenib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Enasidenib Sales by Country (2017-2022) & (K Units)
Table 34. Americas Enasidenib Sales Market Share by Country (2017-2022)
Table 35. Americas Enasidenib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Enasidenib Revenue Market Share by Country (2017-2022)
Table 37. Americas Enasidenib Sales by Type (2017-2022) & (K Units)
Table 38. Americas Enasidenib Sales Market Share by Type (2017-2022)
Table 39. Americas Enasidenib Sales by Application (2017-2022) & (K Units)
Table 40. Americas Enasidenib Sales Market Share by Application (2017-2022)
Table 41. APAC Enasidenib Sales by Region (2017-2022) & (K Units)
Table 42. APAC Enasidenib Sales Market Share by Region (2017-2022)
Table 43. APAC Enasidenib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Enasidenib Revenue Market Share by Region (2017-2022)
Table 45. APAC Enasidenib Sales by Type (2017-2022) & (K Units)
Table 46. APAC Enasidenib Sales Market Share by Type (2017-2022)
Table 47. APAC Enasidenib Sales by Application (2017-2022) & (K Units)
Table 48. APAC Enasidenib Sales Market Share by Application (2017-2022)
Table 49. Europe Enasidenib Sales by Country (2017-2022) & (K Units)
Table 50. Europe Enasidenib Sales Market Share by Country (2017-2022)
Table 51. Europe Enasidenib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Enasidenib Revenue Market Share by Country (2017-2022)
Table 53. Europe Enasidenib Sales by Type (2017-2022) & (K Units)
Table 54. Europe Enasidenib Sales Market Share by Type (2017-2022)
Table 55. Europe Enasidenib Sales by Application (2017-2022) & (K Units)
Table 56. Europe Enasidenib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Enasidenib Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Enasidenib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Enasidenib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Enasidenib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Enasidenib Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Enasidenib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Enasidenib Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Enasidenib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Enasidenib
Table 66. Key Market Challenges & Risks of Enasidenib
Table 67. Key Industry Trends of Enasidenib
Table 68. Enasidenib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Enasidenib Distributors List
Table 71. Enasidenib Customer List
Table 72. Global Enasidenib Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Enasidenib Sales Market Forecast by Region
Table 74. Global Enasidenib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Enasidenib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Enasidenib Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Enasidenib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Enasidenib Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Enasidenib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Enasidenib Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Enasidenib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Enasidenib Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Enasidenib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Enasidenib Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Enasidenib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Enasidenib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Enasidenib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Enasidenib Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Enasidenib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Enasidenib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Enasidenib Revenue Market Share Forecast by Application (2023-2028)
Table 92. Celgene Corporation Basic Information, Enasidenib Manufacturing Base, Sales Area and Its Competitors
Table 93. Celgene Corporation Enasidenib Product Offered
Table 94. Celgene Corporation Enasidenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Celgene Corporation Main Business
Table 96. Celgene Corporation Latest Developments
List of Figures
Figure 1. Picture of Enasidenib
Figure 2. Enasidenib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enasidenib Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Enasidenib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Enasidenib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 100mg
Figure 11. Global Enasidenib Sales Market Share by Type in 2021
Figure 12. Global Enasidenib Revenue Market Share by Type (2017-2022)
Figure 13. Enasidenib Consumed in Hospital
Figure 14. Global Enasidenib Market: Hospital (2017-2022) & (K Units)
Figure 15. Enasidenib Consumed in Pharmacy
Figure 16. Global Enasidenib Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Global Enasidenib Sales Market Share by Application (2017-2022)
Figure 18. Global Enasidenib Revenue Market Share by Application in 2021
Figure 19. Enasidenib Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Enasidenib Revenue Market Share by Company in 2021
Figure 21. Global Enasidenib Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Enasidenib Revenue Market Share by Geographic Region in 2021
Figure 23. Global Enasidenib Sales Market Share by Region (2017-2022)
Figure 24. Global Enasidenib Revenue Market Share by Country/Region in 2021
Figure 25. Americas Enasidenib Sales 2017-2022 (K Units)
Figure 26. Americas Enasidenib Revenue 2017-2022 ($ Millions)
Figure 27. APAC Enasidenib Sales 2017-2022 (K Units)
Figure 28. APAC Enasidenib Revenue 2017-2022 ($ Millions)
Figure 29. Europe Enasidenib Sales 2017-2022 (K Units)
Figure 30. Europe Enasidenib Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Enasidenib Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Enasidenib Revenue 2017-2022 ($ Millions)
Figure 33. Americas Enasidenib Sales Market Share by Country in 2021
Figure 34. Americas Enasidenib Revenue Market Share by Country in 2021
Figure 35. United States Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Enasidenib Sales Market Share by Region in 2021
Figure 40. APAC Enasidenib Revenue Market Share by Regions in 2021
Figure 41. China Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Enasidenib Sales Market Share by Country in 2021
Figure 48. Europe Enasidenib Revenue Market Share by Country in 2021
Figure 49. Germany Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Enasidenib Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Enasidenib Revenue Market Share by Country in 2021
Figure 56. Egypt Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Enasidenib Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Enasidenib in 2021
Figure 62. Manufacturing Process Analysis of Enasidenib
Figure 63. Industry Chain Structure of Enasidenib
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
